Purpose: This prospective study evaluated the recurrence rate in 715 patients with
differentiated thyroid cancer who had no evidence of persistent disease after total …

Abstract Background: Serum thyroglobulin (Tg) is the marker of differentiated thyroid cancer
after initial treatment and TSH stimulation increases its sensitivity for the diagnosis of …

The follow-up of patients with papillary and follicular thyroid carcinoma after thyroidectomy
and radioiodine ablation is mainly based on serum thyroglobulin (Tg) level deter-mination …

Design: This was a retrospective clinical study. Setting: The study was conducted at a
university-based tertiary cancer hospital. Patients: One hundred seven patients had initial …

Serial weekly serum samples (for 3 weeks) were obtained from 42 patients with
differentiated thyroid cancer (DTC, papillary no.= 35, follicular no.= 6, Hürthle cell no.= 1) for …

Objective This retrospective study describes the role of serum thyroglobulin (Tg) in relation
to tumor characteristics in the prediction of persistent/recurrent disease in patients with …

Background Local and regional recurrences occur in up to 20% of patients with papillary
and follicular thyroid carcinoma. Diagnostic work‐up and treatment modalities are still …

Background The use of thyroglobulin (Tg) and thyroglobulin antibodies (TgAb) for detecting
disease recurrence is well validated following total thyroidectomy and radioiodine ablation …

The aim of our study was to evaluate and compare in thyroid cancer patients the predictive
value for disease progression of thyroglobulin (Tg) levels measured under thyroid …

Summary objective To investigate to what extent thyroid remnant ablation and withdrawal
from thyroxine are required to achieve sufficient accuracy of serum thyroglobulin (Tg) …